HUM vs ORGO · P/E 39, rev $129.66B vs rev $482.0M
Humana Inc (HUM) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ORGO revenue for 2024-12-31 was $482.0M. Net income was $861.0K. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. ORGO currently screens at market cap $301.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the HUM and ORGO stock pages for the full models.
Not investment advice.